Venture Life has completed the sale of its Ultradex and Dentyl oral-care brands to Covestus Holdings for up to £4.5 million. The AIM-listed consumer healthcare group received £3.75m in cash on completion, with a further earn-out of up to £750,000 dependent on the assets hitting agreed trading targets over the next 12 months. The Berkshire-based … Continue reading Venture Life sells two brands to Covestus in £4.5m deal